Sinphar Pharmaceutical Co. Ltd.(TW:1734)
NT$30.15+0.05 (+0.17%)
TW:1734
Sinphar Pharmaceutical Co. Ltd. stock forecast
NT$30.15
At close:+0.05 (+0.17%)
Sinphar Pharmaceutical Co. Ltd. (1734) Stock Forecast & Price Target
1734 Analyst Ratings
Currently, no data available
1734 Stock 12 Month Forecast
There Are No Analyst Ratings for 1734 In The Last 3 Months.
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| xAI - Grok-4.3 | TipRanks - xAI | NT$33 | buy | 9.45%Upside | Initiated | 11/10/26 | ||
| PerPlexity - SonarReasoningPro | TipRanks - PerPlexity | NT$33 | hold | 9.45%Upside | Initiated | 11/10/26 | ||
| DeepSeek - V4Pro | TipRanks - DeepSeek | NT$32 | hold | 6.14%Upside | Initiated | 11/10/26 | ||
| Google General EU | TipRanks - Google | NT$34 | buy | 12.77%Upside | Initiated | 11/09/26 | ||
| Anthropic General EU | TipRanks - Anthropic | NT$32 | hold | 6.14%Upside | Initiated | 11/09/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| xAI - Grok-4.3TipRanks - xAI | BuyInitiatedNT$33 | 11/10/26 | 9.45%Upside | ||
| PerPlexity - SonarReasoningProTipRanks - PerPlexity | HoldInitiatedNT$33 | 11/10/26 | 9.45%Upside | ||
| DeepSeek - V4ProTipRanks - DeepSeek | HoldInitiatedNT$32 | 11/10/26 | 6.14%Upside | ||
| Google General EUTipRanks - Google | BuyInitiatedNT$34 | 11/09/26 | 12.77%Upside | ||
| Anthropic General EUTipRanks - Anthropic | HoldInitiatedNT$32 | 11/09/26 | 6.14%Upside |
Stocks with the Highest Top Analyst Consensus in the General Sector
1734 Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, 1734 has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 1734 average Analyst price target in the past 3 months is ―.
1734 Financial Forecast
ConsensusNT$0.32
1734 Earnings Forecast
Next quarter’s earnings estimate for 1734 is TWD 0.32 with a range of ― to ―. The previous quarter’s EPS was TWD 0.32. Its overall industry beat the EPS estimate 50.49% of the time in the past 12 months.
ConsensusNT$850M
1734 Sales Forecast
Next quarter’s sales forecast for 1734 is TWD 849.61M with a range of ― to ―. The previous quarter’s sales results were TWD 849.61M. Its overall industry beat sales estimates 63.25% of the time in the past 12 months.
1734 Stock Forecast FAQ
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
What do analysts say about Sinphar Pharmaceutical Co. Ltd.?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of Sinphar Pharmaceutical Co. Ltd.?
To buy shares of TW:1734, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
